Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sean M Davidson

Showing results (101-110 of 171) with videos related to

Pageof 18
Sort By:
Cardiovascular Drugs and Therapy|February 16, 2022
Do We Really Need Aspirin Loading for STEMI?Regina Ye, Hani Jneid, Mahboob Alam, et al.
American Journal of Physiology. Heart and Circulatory Physiology|March 23, 2011
Enhancing AMPK activation during ischemia protects the diabetic heart against reperfusion injuryMarta A Paiva, Zoe Rutter-Locher, Lino M Gonçalves, et al.
Basic Research in Cardiology|October 30, 2024
Investigating the cause of cardiovascular dysfunction in chronic kidney disease: capillary rarefaction and inflammation may contribute to detrimental cardiovascular outcomesSiavash Beikoghli Kalkhoran, Maryna Basalay, Zhenhe He, et al.
Cardiovascular Research|November 15, 2018
The coronary circulation in acute myocardial ischaemia/reperfusion injury: a target for cardioprotectionDerek J Hausenloy, William Chilian, Filippo Crea, et al.
The Journal of Biological Chemistry|November 26, 2011
Photoaffinity labeling of nicotinic acid adenine dinucleotide phosphate (NAADP) targets in mammalian cellsYaping Lin-Moshier, Timothy F Walseth, Dev Churamani, et al.
Basic Research in Cardiology|December 15, 2007
Metformin protects the ischemic heart by the Akt-mediated inhibition of mitochondrial permeability transition pore openingGurpreet S Bhamra, Derek J Hausenloy, Sean M Davidson, et al.
Journal of Cardiovascular Pharmacology and Therapeutics|December 25, 2010
Failure of the adipocytokine, resistin, to protect the heart from ischemia-reperfusion injuryChristopher C T Smith, Shiang Y Lim, Abigail M Wynne, et al.
The International Journal of Biochemistry & Cell Biology|October 12, 2010
Transgenic overexpression of HSP56 does not result in cardiac hypertrophy nor protect from ischaemia/reperfusion injuryChristopher J Carroll, Naushaad Suleman, Sean M Davidson, et al.
Biochemical and Biophysical Research Communications|September 11, 2004
The cardioprotective effect of urocortin during ischaemia/reperfusion involves the prevention of mitochondrial damageKevin M Lawrence, Paul A Townsend, Sean M Davidson, et al.
Basic Research in Cardiology|September 13, 2021
IMproving Preclinical Assessment of Cardioprotective Therapies (IMPACT) criteria: guidelines of the EU-CARDIOPROTECTION COST ActionSandrine Lecour, Ioanna Andreadou, Hans Erik Bøtker, et al.
Pageof 18

Showing results (101-110 of 171) with videos related to

Sort By:
Pageof 18
Cardiovascular Drugs and Therapy|February 16, 2022
Do We Really Need Aspirin Loading for STEMI?Regina Ye, Hani Jneid, Mahboob Alam, et al.
American Journal of Physiology. Heart and Circulatory Physiology|March 23, 2011
Enhancing AMPK activation during ischemia protects the diabetic heart against reperfusion injuryMarta A Paiva, Zoe Rutter-Locher, Lino M Gonçalves, et al.
Basic Research in Cardiology|October 30, 2024
Investigating the cause of cardiovascular dysfunction in chronic kidney disease: capillary rarefaction and inflammation may contribute to detrimental cardiovascular outcomesSiavash Beikoghli Kalkhoran, Maryna Basalay, Zhenhe He, et al.
Cardiovascular Research|November 15, 2018
The coronary circulation in acute myocardial ischaemia/reperfusion injury: a target for cardioprotectionDerek J Hausenloy, William Chilian, Filippo Crea, et al.
The Journal of Biological Chemistry|November 26, 2011
Photoaffinity labeling of nicotinic acid adenine dinucleotide phosphate (NAADP) targets in mammalian cellsYaping Lin-Moshier, Timothy F Walseth, Dev Churamani, et al.
Basic Research in Cardiology|December 15, 2007
Metformin protects the ischemic heart by the Akt-mediated inhibition of mitochondrial permeability transition pore openingGurpreet S Bhamra, Derek J Hausenloy, Sean M Davidson, et al.
Journal of Cardiovascular Pharmacology and Therapeutics|December 25, 2010
Failure of the adipocytokine, resistin, to protect the heart from ischemia-reperfusion injuryChristopher C T Smith, Shiang Y Lim, Abigail M Wynne, et al.
The International Journal of Biochemistry & Cell Biology|October 12, 2010
Transgenic overexpression of HSP56 does not result in cardiac hypertrophy nor protect from ischaemia/reperfusion injuryChristopher J Carroll, Naushaad Suleman, Sean M Davidson, et al.
Biochemical and Biophysical Research Communications|September 11, 2004
The cardioprotective effect of urocortin during ischaemia/reperfusion involves the prevention of mitochondrial damageKevin M Lawrence, Paul A Townsend, Sean M Davidson, et al.
Basic Research in Cardiology|September 13, 2021
IMproving Preclinical Assessment of Cardioprotective Therapies (IMPACT) criteria: guidelines of the EU-CARDIOPROTECTION COST ActionSandrine Lecour, Ioanna Andreadou, Hans Erik Bøtker, et al.
Pageof 18